Filing Details
- Accession Number:
- 0001209191-15-015052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-02-18 09:21:43
- Reporting Period:
- 2015-02-17
- Filing Date:
- 2015-02-18
- Accepted Time:
- 2015-02-18 09:21:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533040 | Rxi Pharmaceuticals Corp | RXII | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1285648 | Geert Cauwenbergh | C/O Rxi Pharmaceuticals Corporation 257 Simarano Drive, Suite 101 Marlborough MA 01752 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2015-02-17 | 4,000 | $1.17 | 62,500 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.0001 Par Value | 5,000 | Indirect | By spouse |
Common Stock, $0.0001 Par Value | 4,500 | Indirect | By child |
Footnotes
- Represents shares held by the Reporting Person's son. The Reporting Person disclaims beneficial ownership of such shares and this report shall not constitute an admission of beneficial ownership.